These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 15297806)

  • 21. Genotype frequency of plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism in healthy Japanese males and its relation to PAI-1 levels.
    Matsubara Y; Murata M; Isshiki I; Watanabe R; Zama T; Watanabe G; Watanabe K; Ikeda Y
    Int J Hematol; 1999 Jan; 69(1):43-7. PubMed ID: 10641442
    [TBL] [Abstract][Full Text] [Related]  

  • 22. No association of the plasminogen activator inhibitor-1 promoter 4G/5G polymorphism with inhibitor level during basal transcription in vitro.
    Zhan M; Zhou Y; Han ZC
    Int J Hematol; 2004 May; 79(4):400-4. PubMed ID: 15218974
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 4G/5G polymorphism modulates PAI-1 circulating levels in obese women.
    Fernandes KS; Sandrim VC
    Mol Cell Biochem; 2012 May; 364(1-2):299-301. PubMed ID: 22258825
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of TCF7L2 gene polymorphisms with reduced acute insulin response in Hispanic Americans.
    Palmer ND; Lehtinen AB; Langefeld CD; Campbell JK; Haffner SM; Norris JM; Bergman RN; Goodarzi MO; Rotter JI; Bowden DW
    J Clin Endocrinol Metab; 2008 Jan; 93(1):304-9. PubMed ID: 17971425
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasminogen activator inhibitor type-1 (PAI-1) polymorphism 4G/5G is associated with prostate cancer among men with a positive family history.
    Jorgenson E; Deitcher SR; Cicek M; Liu X; Plummer S; Casey G; Witte JS
    Prostate; 2007 Feb; 67(2):172-7. PubMed ID: 17044080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of -675 4G/5G in the plasminogen activator inhibitor-1 gene and -308G/A tumor necrosis factor-α gene polymorphisms in obese Argentinean patients.
    Wingeyer SD; Graffigna MN; Belli SH; Benetucci J; de Larrañaga GF
    Genet Test Mol Biomarkers; 2012 May; 16(5):372-5. PubMed ID: 22106856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The 4G/5G sequence polymorphism in the promoter of plasminogen activator inhibitor-1 (PAI-1) gene: relationship to plasma PAI-1 level in venous thromboembolism.
    Stegnar M; Uhrin P; Peternel P; Mavri A; Salobir-Pajnic B; Stare J; Binder BR
    Thromb Haemost; 1998 May; 79(5):975-9. PubMed ID: 9609232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasminogen activator inhibitor-1 4G/5G gene polymorphism in patients with myocardial or cerebrovascular infarction in Tianjin, China.
    Zhan M; Zhou Y; Han Z
    Chin Med J (Engl); 2003 Nov; 116(11):1707-10. PubMed ID: 14642142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of PAI-1 4G/5G and -844G/A gene polymorphisms and changes in PAI-1/tissue plasminogen activator levels in myocardial infarction: a case-control study.
    Abboud N; Ghazouani L; Saidi S; Ben-Hadj-Khalifa S; Addad F; Almawi WY; Mahjoub T
    Genet Test Mol Biomarkers; 2010 Feb; 14(1):23-7. PubMed ID: 19929406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contribution of the type 1 plasminogen activator inhibitor 4G/5G gene polymorphism to impaired fibrinolysis in vital exhaustion.
    von Känel R; Maly FE; Frey K; Fischer JE
    Ital Heart J; 2003 Nov; 4(11):791-6. PubMed ID: 14699709
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative trait loci for abdominal fat and BMI in Hispanic-Americans and African-Americans: the IRAS Family study.
    Norris JM; Langefeld CD; Scherzinger AL; Rich SS; Bookman E; Beck SR; Saad MF; Haffner SM; Bergman RN; Bowden DW; Wagenknecht LE
    Int J Obes (Lond); 2005 Jan; 29(1):67-77. PubMed ID: 15534617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PAI-1 polymorphisms modulate phenotypes associated with the metabolic syndrome in obese and diabetic Caucasian population.
    Lopes C; Dina C; Durand E; Froguel P
    Diabetologia; 2003 Sep; 46(9):1284-90. PubMed ID: 12856128
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The 4G/5G polymorphism of the plasminogen activator inhibitor gene is associated with the time course of progression to acute coronary syndromes.
    Iwai N; Shimoike H; Nakamura Y; Tamaki S; Kinoshita M
    Atherosclerosis; 1998 Jan; 136(1):109-14. PubMed ID: 9544737
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relationship between plasma t-PA and PAI-1 levels is dependent on epistatic effects of the ACE I/D and PAI-1 4G/5G polymorphisms.
    Moore JH; Smolkin ME; Lamb JM; Brown NJ; Vaughan DE
    Clin Genet; 2002 Jul; 62(1):53-9. PubMed ID: 12123488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism and endometriosis. Influence of PAI-1 polymorphism on PAI-1 antigen and mRNA expression.
    Ramón LA; Gilabert-Estellés J; Cosín R; Gilabert J; España F; Castelló R; Chirivella M; Romeu A; Estellés A
    Thromb Res; 2008; 122(6):854-60. PubMed ID: 18423526
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The common -675 4G/5G polymorphism in the plasminogen activator inhibitor -1 gene is strongly associated with obesity.
    Hoffstedt J; Andersson IL; Persson L; Isaksson B; Arner P
    Diabetologia; 2002 Apr; 45(4):584-7. PubMed ID: 12032637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comprehensive survey of common genetic variation at the plasminogen activator inhibitor-1 locus and relations to circulating plasminogen activator inhibitor-1 levels.
    Kathiresan S; Gabriel SB; Yang Q; Lochner AL; Larson MG; Levy D; Tofler GH; Hirschhorn JN; O'Donnell CJ
    Circulation; 2005 Sep; 112(12):1728-35. PubMed ID: 16172282
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship of plasminogen activator inhibitor 1 gene 4G/5G polymorphisms to hypertension in Korean women.
    Kim KN; Kim KM; Kim BT; Joo NS; Cho DY; Lee DJ
    Chin Med J (Engl); 2012 Apr; 125(7):1249-53. PubMed ID: 22613596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Promoter (4G/5G) plasminogen activator inhibitor-1 genotype in Pima Indians: relationship to plasminogen activator inhibitor-1 levels and features of the insulin resistance syndrome.
    McCormack LJ; Nagi DK; Stickland MH; Mansfield MW; Mohamed-Ali V; Yudkin JS; Knowler WC; Grant PJ
    Diabetologia; 1996 Dec; 39(12):1512-8. PubMed ID: 8960834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PAI-1 4G/5G polymorphism and plasma levels association in patients with coronary artery disease.
    Lima LM; Carvalho Md; Fonseca Neto CP; Garcia JC; Sousa MO
    Arq Bras Cardiol; 2011 Dec; 97(6):462-389. PubMed ID: 22011808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.